Antivirals Flashcards

1
Q

What viruses does tecovirimat have activity against and what is the target?

A

All orthopoxvirus - it target and inhibits orthopox VP37, inhibiting viral egress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which antivirals can be used against smallpox?

A

Tecovirimat and brincidofovir (or cidofovir)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is trifluradine used for?

A

Eye drops for HSV and vaccinia keratitis. It is a nucleoside analogue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is brivudine?

A

Nucleoside analogue license ld to treat shingles, but not in UK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Is cidofovir virostatic or virocidal?

A

Virostatic - immune response required to clear infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the main amantadine resistance mutation in influenza A?

A

S31N

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What antivirals are available for influenza? Name 8 antivirals

A

M2 ion channels

Amantadine
Rimantidine

Neuraminidase inhibitors

  Oseltamivir 
  Zanamavir
  Peramivir
  Laninamivir

Polymerase inhibitors

 Baloxavir 
 Favipirivir
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the mechanism of action of adamantanes?

What virus is this active against?

A

Blocks hydrogen ion influx through M2 ion channel, preventing viral uncoating

Active against flu A but not flu B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the mechanism of action of the neuraminidase inhibitors?

A

Analogs of sialic acid, bind the cleavage site of NA so it can’t cleave HA from sialic acid and therefore virus can not be released

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name two influenza polymerase inhibitors and their targets

A

Baloxivir - PA - inhibits cap-dependent endonuclease

Favipirivir - PB1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the most common resistance mutations to oseltamivir and zanamavir?

A

Oseltamivir

H1N1 - H275Y
H3N2 - E119V and R292K

Zanamivir

H1N1/H3N2 - Q136K
H3N2 - R292K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What administration routes are 1) oseltamivir, 2) zanamivir, 3) peramivir, 4) baloxivir

A

1) oral
2) inhaled and IV
3) IV infusion
4) oral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the administrative route, dose regime and most common resistance mutation for baloxivir?

A

Oral
Single dose
I38T/M/F (more common in H3N2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nucleos(t)ide analogues with activity against HSV?

A

Nucleoside
-Acivlovir
-Ganciclovir (less activity but still some)
-Famciclovir (acetylated
penciclovir)

Nucelotide
- Cidofovir
- Adefovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Non nucleos(t)ide inhibitors with activity against HSV?

A

Foscarnet - pyrophosphate analogue

Pritelivir - Helicase/Primase inhibitor

Amenamevir - (not in use in the UK - approved in Japan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HSV gene mutations conferring resistance to aciclovir and result of mutation?

A

UL23 - TK (95%)
UL30 - DNA pol (5%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Relevant gene mutations in HSV

A

UL 23 - TK - confers ACV resistance
UL30 - DNA pol - Multi class resistance possible - ACV, FOS, CID
UL5/UL52/UL8 - DNA helicase/primase - possible pritelivir resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Name two helicase-primase inhibitors with activity against HSV

A

Pritelivir

Amenamevir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Can tecovirimat be used in pregnancy?

A

Not licensed, should only be used if severe disease, breastfeeding contraindicated.

Vertical transmission is possible (highest risk in first trimester) baby to be tested at birth (throat, urine, blood) if negative vaccinate baby

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mechanism of action of pocapavir and limitation of treatment

A

Enterovirus specific capsid inhibitor - blocks viral uncoating and RNA release

Difficult to procure and can only be used for 2 weeks in total

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Name two IL-6 receptor antagonists for use in COVID infection. When would you initiate these? What should you be cautious of?

A

Tocilizumab and Sarilumab

When patients are on oxygen and corticosteroids

Sarilumab is not licensed but can be used if Tocilizumab unavailable

Potent immunosuppressors so patients are risk of opportunistic infection. Use in immunosuppressed patients requires caution.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Name the JAK-inhibitor used for treating COVID. When would you use this and what are the contraindications?

A

Baricitinib

Age 2+ for patients on oxygen and corticosteroids AND with no evidence of another infection that might be made worse

Can be added to toculizumab or used instead if tocilizumab if it can not be tolerated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When would you use nirmatrelvir and ritonavir (paxlovid)?

A

In patients presenting within 5 days
Not requiring oxygen but are high risk of severe disease

24
Q

What window do you need with treat flu within for the following:

  1. Oseltamivir
  2. Zanamavir in adults
  3. Zanamavir in children
  4. IV Zanamavir
A
  1. Within 48 h (up to 5 days off-label)
  2. Within 48 h
  3. Within 36 h
  4. Within 6 days
25
Q

In which situations would you consider using IV zanamivir to treat influenza?

A

Severely immunosuppressed patients with complicated flu (in H1 season) who are unable to use diskhaler

Severely immunosuppressed patients with severe complications such as multi organ failure (in H1 season)

26
Q

In what age is zanamivir licensed? Dose and duration of treatment?

A

Over 5 years

10 mg BD 5 days

27
Q

Do zanamivir and oseltamivir require dose adjustment for

1) renal dysfunction
2) hepatic dysfunction

A

1) Oseltamivir = yes, inhaled zanamavir = no, IV zanamavir = yes

2) Oseltamivir = no, inhaled zanamavir = no, IV zanamavir = yes

28
Q

What class of drug is nirmatrelvir? What drug is added to this to treat COVID? And who would you treat with this regimen?

A

Protease inhibitor

Ritonavir

COVID patients without oxygen requirements, who are at high risk of severe disease

29
Q

What class of drug is remdesivir? When would you use it for COVID treatment? What is administration route?

A

RNA polymerase inhibitors (adenosine nucleotide prodrug)

Patients at high risk of severe disease

IV

30
Q

What is the mechanism of action of molnupiravir? When would you use it in COVID treatment? What is administration route?

A

Nucleoside analogue which causes mutagenesis in the viral RNA

Adults at high risk of disease, within 5 days of symptoms, who do not require O2 (can be used interchangeably with paxlovid)

Oral

31
Q

What class of drug is tocilizumab? What other drug is the same class can be used instead? What specifically are patients at risk of?

A

IL6 receptor antagonist

Sarilumab

Potent immunosuppressant so patients are at risk of opportunistic infection

32
Q

What class of drug is Baricitinib? When specifically should this not be used?

A

Janus Kinase (JAK) inhibitors

Cannot be used if patients have evidence of any other infection that could be made worse with treatment

33
Q

What is Tabelecleucel?

A

Off the shelf EBV specific cytotoxic T cells for use in relapsing and refractory EBV+ PTLD

34
Q

What type of drug is ribavirin?

A

Nucleoside (guanosine) analogue

35
Q

What is rituximab? How long does the induced B cell suppression last for? What are the implications of this?

A

Anti- CD20 MAb

2-6 months

At risk of opportunistic infections and unable to have vaccination during this time due to likely poorer responses

36
Q

What is CAR-T therapy and what implications does it have in virology?

A

Chimeric antigen receptor T cell therapy

Patients T cells are modified to include a receptor to recognise and kill cancer cells

Can be used in refractory B cell ALL, DLBCL, B cell and mantel cell lymphoma

Patients are severely immunosuppressed and can be at risk of viral reactivation and opportunistic infection

37
Q

What is the treatment for acute disseminated encephalomyelitis?

A

Corticosteroids, IVIG and plasma exchange

38
Q

What is posoleucel?

A

Off the shelf CTL for 6 viruses (adeno, BK, JC, CMV, EBV, HHV-6)

Phase III trails have been cancelled though :(

39
Q

What is lonafarnib?

A

Oral prenylation inhibitor being investigated for HDV treatment (ritonavir boosted +/- IFN)

40
Q

What is Inmazeb and Ebanga?

A

Monoclonals to Ebola Zaire

Inmazeb - REGN-EB3
Ebanga - mAb114

41
Q

Treatment/prophylaxis of PCP?

A

Co-trimoxazole

43
Q

Mechanism of action, administration route and side effects of ganciclovir

A

Nucleoside (guanosine) analogue. Activated into ganciclovir triphosphate, initially by UL97 and then cellular kinases. GCV-triphosphate competitively inhibits incorporation of deoxyguanosine triphosphate. Slows viral replication.

IV (valganciclovir is oral)

Bone marrow suppression

44
Q

Mechanism of action, administration route and side effects of foscarnet

A

Pyrophosphate analogue. Non competitive inhibitor of viral DNA by binding DNA polymerase directly. Does not require phosphorylation

IV

Nephrotoxicity. Hypocalcaemia, electrolyte imbalance (can cause seizures), genital ulceration

45
Q

Mechanism of action, administration route and side effects of cidofovir

A

Acyclic nucleotide (cytodine) analogue. After phosphorylation by cellular kinases, cidofovir diphosphate inhibits DNA polymerase by competitive inhibition of viral DNA polymerase disrupting elongation

IV

Nephrotoxicity - requires probenecid and hyper hydration

46
Q

Mechanism of action, administration route and side effects of letermovir

A

Inhibits DNA synthesis at late stage by targeting UL56 subunit of the terminase enzyme complex

Oral

Low/no side effects

47
Q

Mechanism of action, administration route and side effects of maribavir

A

Inhibition of CMV UL97 by competing with ATP. Does not require intracellular phosphorylation.

Oral

Taste and gastrointestinal disturbances

48
Q

What age and weight is maribavir licensed?

A

Licenced for >12 y and BW >35 kg (although EMA >18 y)

49
Q

What resistance mutations cause maribavir resistance?

A

T409M and H411Y and C480F in UL97

Also resistance mutations in UL27

50
Q

Mechanism of action, administration route and side effects of aciclovir

A

Nucleoside (guanosine) analogue. Selective phosphorylation only in virally infected cells. First phosphorylation step by TK, two further steps by cellular kinases. ACV-triphosphate can be incorporated into DNA causing chain termination.

IV or oral

Few side effects (mostly the usual)

51
Q

What is penciclovir and famciclovir?

A

Penciclovir is a acyclic guanine derivative = short chain terminator

Famciclovir is its oral pro drug

52
Q

Mechanism of action and administration route of pritelevir

A

Helicase primase inhibitor. The helicase-primase complex is composed of 3 proteins encoded by the UL5 (helicase), UL8 (scaffold region), and UL52 (primase)

Single oral tablet daily

53
Q

What is imiquimod?

A

TLR-7/8 agonist that stimulates cytokine production to stimulate Th1 response

Used in aciclovir resistant genital herpes

54
Q

Options for HSCT patients with aciclovir resistant HSV

A

Consider high dose aciclovir (10 mg/kg TDS)

First line = foscarnet, alternative = cidofovir

If not working, can try high dose IV aciclovir 30-45 mg/kg +/- foscarnet

Topical treatments can be tried for those who are at risk of toxicities from systemic agents

55
Q

What is IC50?

A

IC50 (50% inhibitory concentration) concentration of drug that reduces the plaque number by 50% compared to no antiviral